Therapeutic Use of Opioids & Psychiatric Medications for Criminal and DUI Cases
This specialized webinar provides legal professionals with an objective, evidence-based pharmacological
framework for handling complex impairment questions in DUI, assault, custody, and homicide cases.
Designed to separate medical reality from pervasive courtroom misconceptions, the presentation equips
attorneys to distinguish the mere presence of a drug from actual clinical impairment using objective
clinical signs. Participants will explore how physiological tolerance alters medication effects, learning
why a chronic, stable user can maintain normal cognition and drive safely on a dose that would severely
incapacitate an opioid-naive individual. The curriculum deconstructs common prosecution
overstatements regarding polypharmacy, clarifies the clinical realities of opioid-alcohol co-ingestion, and
debunks myths regarding drug withdrawal. Furthermore, the session demystifies psychiatric drug
classes, explaining why medications like "antipsychotics" are routinely prescribed for non-psychotic
conditions such as insomnia or depression, which can otherwise unfairly prejudice a jury. Finally,
attendees will learn how to systematically review prescription histories, recognize the steep limitations
of toxicology screens, and structure strategic cross-examinations of Drug Recognition Expert (DRE)
testimony to challenge subjective assumptions with patient-specific data.
Highlights / Agenda
● Presence Does Not Equal Impairment
● The Power of Physiological Tolerance
● Mislabeled Drug Classes Prejudice Juries
● Urine Testing is Useless for Acute Impairment
● Debunking the "Withdrawal Rage" Myth
● Polypharmacy is Often Safe and Stable
framework for handling complex impairment questions in DUI, assault, custody, and homicide cases.
Designed to separate medical reality from pervasive courtroom misconceptions, the presentation equips
attorneys to distinguish the mere presence of a drug from actual clinical impairment using objective
clinical signs. Participants will explore how physiological tolerance alters medication effects, learning
why a chronic, stable user can maintain normal cognition and drive safely on a dose that would severely
incapacitate an opioid-naive individual. The curriculum deconstructs common prosecution
overstatements regarding polypharmacy, clarifies the clinical realities of opioid-alcohol co-ingestion, and
debunks myths regarding drug withdrawal. Furthermore, the session demystifies psychiatric drug
classes, explaining why medications like "antipsychotics" are routinely prescribed for non-psychotic
conditions such as insomnia or depression, which can otherwise unfairly prejudice a jury. Finally,
attendees will learn how to systematically review prescription histories, recognize the steep limitations
of toxicology screens, and structure strategic cross-examinations of Drug Recognition Expert (DRE)
testimony to challenge subjective assumptions with patient-specific data.
Highlights / Agenda
● Presence Does Not Equal Impairment
● The Power of Physiological Tolerance
● Mislabeled Drug Classes Prejudice Juries
● Urine Testing is Useless for Acute Impairment
● Debunking the "Withdrawal Rage" Myth
● Polypharmacy is Often Safe and Stable
